In the 1970s, an unknown virus was suspected for documented cases of transfusion-
associated hepatitis, a phenomenon called non-A, non-B hepatitis. In 1989, the infectious …

Hepatitis C virus (HCV) infection represents an important public health problem worldwide.
Reduction of HCV morbidity and mortality is a current challenge owned to several viral and …

Current and Future Therapies for Hepatitis C Virus Infection | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …

The face of future hepatitis C antiviral drug development: Recent biological and virologic
advances and their translation to drug development and clinical practice - ScienceDirect Skip …

The complications of chronic hepatitis C virus infection can be prevented by antiviral
therapy. The initial choice of interferon alfa and, subsequently, ribavirin as potential …

The development of new models and tools has led to the discovery and clinical development
of a large number of new anti-hepatitis C virus (HCV) drugs, including direct-acting antivirals …

Almost 25 years after the hepatitis C virus (HCV) was identified, and following intense
research and development efforts, a large number of direct-acting antiviral drugs are now …

Chronic hepatitis C virus (HCV) infection affects a large number of patients worldwide. While
our current therapies (Table 1) are effective in approximately 50% of patients, therapy is …

Hepatitis C virus (HCV) will continue to be a serious global health threat for many years to
come because of the chronic nature of the infection, its high prevalence and the significant …

Hepatitis C in a New Era: A Review of Current Therapies - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …